Shenyang, Liaoning, China In 1993 was created 3sbio, which is appeared as Corporate Investor. The fund was located in Asia if to be more exact in China. The leading representative office of defined Corporate Investor is situated in the Shenyang.
The important activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the 3sbio, startups are often financed by WuXi Healthcare Ventures, Shangbay Capital, 3E Bioventures. The meaningful sponsors for the fund in investment in the same round are WuXi Healthcare Ventures, Sofinnova Partners, Shangbay Capital.
Among the most popular portfolio startups of the fund, we may highlight Refuge Biotechnologies. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Therapeutics, Genetics.
Related Funds
| Fund Name | Location |
| Brazos Private Equity Partners | Dallas, Texas, United States |
| Claridge Israel | Herzliya, Israel, Tel Aviv |
| Construct Capital | - |
| Dansk Innovation | - |
| Gongqingcheng Angcheng Touzi | China, Shanghai |
| Huagong Venture Capital | China, Hubei, Wuhan |
| Iron Fund | Atlanta, Georgia, United States |
| JD MRO | Beijing, Beijing, China |
| Jetty Ventures | Central, Central Region, Singapore |
| Lakefield Ventures | - |
| North Run Capital Partners | Boston, Massachusetts, United States |
| Oceanic Partners | California, Sausalito, United States |
| PT Media Nusantara Citra Tbk. (MNC Media Group) | Indonesia, Jakarta Pusat, Jakarta Raya |
| Qianhai Yujun Capital | - |
| Riverside Medical Group | - |
| Sosei CVC | Chiyoda, Japan |
| Structural Capital | California, Menlo Park, United States |
| Symmetry Peak Management | Pennsylvania, Radnor, United States |
| The Orogen Group | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Allorion Therapeutics | $50M | 09 Mar 2023 | Natick, Massachusetts, United States | ||
Numab | $23M | 12 Dec 2019 | Zurich, Switzerland | ||
Refuge Biotechnologies | $25M | 02 May 2018 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Allorion Therapeutics | $50M | 09 Mar 2023 | Natick, Massachusetts, United States | ||
Numab | $23M | 12 Dec 2019 | Zurich, Switzerland | ||
Refuge Biotechnologies | $25M | 02 May 2018 | California, United States |
